Often, pharmaceutical companies avoid new laboratory testing methodologies preferring to stick to established procedures for drug development so as to avoid any potential regulatory ambiguity. This tendency to avoid new methodologies and regulatory scrutiny sometimes leads to slower progress, higher costs and lower probability of new product approvals. Furthermore, some pharmaceutical firms severely restrict academic research-based modifications to established laboratory testing procedures in drug development because of their concern over triggering costly adjustments to the established regulatory framework.
CAL provides analytical services for the quality control programs of regulated products with professional expertise for raw materials, finished products, and packaging materials. Good Manufacturing Practices (GMP) help assure regulatory authorities that the data submitted are a true reflection of the results obtained during the study and can therefore be relied upon when making risk or safety assessments for regulated consumer products.
CPR Medical Devices, Inc. is a developer and manufacturer of patient-responsive emergency ventilation devices based on patented technology. These unique ventilatory devices are sold around the globe by independent distributors to EMS, hospitals, professionals and first responders. CPR's medical devices are marketed under the registered trade name Oxylator. They are simple, safe and effective, yet competitvely priced and are often teamed up with an AED (automatic external defibrillator) for most effective cardiopulmonary resuscitation.